10th February 2015
In Part 3 of his nine-part product review of AdisInsight, Springer's new database of scientifically curated drug information, Ashish Shukla looks at its coverage of information on drugs in commercial development worldwide. He gives a detailed assessment of how the platform consistently organises its drug profiles, which are updated daily.
Note: Full review (PDF) at https://web.jinfo.com/go/sub/report/2468
Access to Jinfo articles and reports is a benefit of a Jinfo Subscription.
Please sign in here so that we can check your access to this item:
If this item has been shared with you by a colleague, please request a MyJinfo account.
Gain access to this article with a Jinfo Subscription. It will help your organisation:
Benefits and Pricing
Submit the Subscription Question form to find out if someone in your organisation already has a subscription or to discuss your questions or requirements.Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
Claire LaybatsHead of Commercial Developmentclaire.firstname.lastname@example.org
Related Subscription Articles:
Related Subscription Reports:
Back to top ^
« All Articles
Login to MyJinfo if you already have a Jinfo Subscription
"Remote Information Teams"
If you're newly remote, you may feel like you've been thrown into a mysterious culture where you sort of speak the language but sort of not. Use Jinfo's "Focus on Remote Information Teams" to become fluent: